This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Factory, Inc.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Koichi Ogino: Innovator in Streptokinase Protein Development
Introduction
Koichi Ogino is a notable inventor based in Naruto, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of mutated streptokinase proteins. His work has implications for medical treatments and therapeutic applications.
Latest Patents
Ogino holds a patent for his invention related to mutated streptokinase proteins. This invention involves a novel chemically synthesized gene that includes a base sequence coding for the primary amino acid sequence of natural-type streptokinase. The patent also covers a corresponding plasmid recombinant, a transformant, and a process for preparing streptokinase through the incubation of the transformant. Additionally, it relates to novel streptokinase derivative proteins that possess streptokinase activity and a modified primary amino acid sequence, which may be deficient, replaced, or inserted at specific positions.
Career Highlights
Koichi Ogino is associated with Otsuka Pharmaceutical Factory, Inc., where he has contributed to various research and development projects. His work in the field of biotechnology has been recognized for its innovative approach to protein synthesis and modification.
Collaborations
Ogino has collaborated with several professionals in his field, including Kaoruko Takada and Setsuro Fujii, who have contributed to his research endeavors.
Conclusion
Koichi Ogino's contributions to the development of mutated streptokinase proteins highlight his innovative spirit and dedication to advancing biotechnology. His work continues to influence the medical field and showcases the importance of research and collaboration in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
